322 related articles for article (PubMed ID: 10828763)
21. Vascular endothelial growth factor (VEGF) in children, adolescents and young adults with Type 1 diabetes mellitus: relation to glycaemic control and microvascular complications.
Chiarelli F; Spagnoli A; Basciani F; Tumini S; Mezzetti A; Cipollone F; Cuccurullo F; Morgese G; Verrotti A
Diabet Med; 2000 Sep; 17(9):650-6. PubMed ID: 11051284
[TBL] [Abstract][Full Text] [Related]
22. Plasma high-sensitivity troponin T predicts end-stage renal disease and cardiovascular and all-cause mortality in patients with type 1 diabetes and diabetic nephropathy.
Galsgaard J; Persson F; Hansen TW; Jorsal A; Tarnow L; Parving HH; Rossing P
Kidney Int; 2017 Nov; 92(5):1242-1248. PubMed ID: 28712855
[TBL] [Abstract][Full Text] [Related]
23. Smoking and progression of diabetic nephropathy in type 1 diabetes.
Hovind P; Rossing P; Tarnow L; Parving HH
Diabetes Care; 2003 Mar; 26(3):911-6. PubMed ID: 12610058
[TBL] [Abstract][Full Text] [Related]
24. [Cardiovascular autonomic neuropathy and nephropathy in patients with type-1 diabetes mellitus].
Galicka-Latała D; Fedak D; Kuźniewski M; Kawalec E; Solnica B
Przegl Lek; 2004; 61(3):155-8. PubMed ID: 15518324
[TBL] [Abstract][Full Text] [Related]
25. Elevated matrix metalloproteinase-2 and -9 in urine, but not in serum, are markers of type 1 diabetic nephropathy.
Diamant M; Hanemaaijer R; Verheijen JH; Smit JW; Radder JK; Lemkes HH
Diabet Med; 2001 May; 18(5):423-4. PubMed ID: 11472458
[No Abstract] [Full Text] [Related]
26. Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathy.
Burgos R; Simó R; Audí L; Mateo C; Mesa J; García-Ramírez M; Carrascosa A
Diabetologia; 1997 Sep; 40(9):1107-9. PubMed ID: 9300249
[TBL] [Abstract][Full Text] [Related]
27. Markers of endothelial dysfunction and inflammation in type 1 diabetic patients with or without diabetic nephropathy followed for 10 years: association with mortality and decline of glomerular filtration rate.
Astrup AS; Tarnow L; Pietraszek L; Schalkwijk CG; Stehouwer CD; Parving HH; Rossing P
Diabetes Care; 2008 Jun; 31(6):1170-6. PubMed ID: 18332153
[TBL] [Abstract][Full Text] [Related]
28. Hypoxic induction of vascular endothelial growth factor is markedly decreased in diabetic individuals who do not develop retinopathy.
Marsh S; Nakhoul FM; Skorecki K; Rubin A; Miller BP; Leibu R; Levy NS; Levy AP
Diabetes Care; 2000 Sep; 23(9):1375-80. PubMed ID: 10977036
[TBL] [Abstract][Full Text] [Related]
29. Correlation between carotid artery distensibility and serum vascular endothelial growth factor concentrations in type 1 diabetic subjects and nondiabetic subjects.
Valabhji J; Dhanjil S; Nicolaides AN; Elkeles RS; Sharp P
Metabolism; 2001 Jul; 50(7):825-9. PubMed ID: 11436189
[TBL] [Abstract][Full Text] [Related]
30. Endothelial cell-selective adhesion molecule in diabetic nephropathy.
Kacso IM; Kacso G
Eur J Clin Invest; 2012 Nov; 42(11):1227-34. PubMed ID: 22957687
[TBL] [Abstract][Full Text] [Related]
31. Aldosterone escape during blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy is associated with enhanced decline in glomerular filtration rate.
Schjoedt KJ; Andersen S; Rossing P; Tarnow L; Parving HH
Diabetologia; 2004 Nov; 47(11):1936-9. PubMed ID: 15551047
[TBL] [Abstract][Full Text] [Related]
32. Study of Angiopoietin-2 and vascular endothelial growth factor as markers of diabetic nephropathy onset in Egyptians diabetic patients with non-albuminuric state.
Aly MH; Arafat MA; Hussein OA; Elsaid HH; Abdel-Hammed AR
Diabetes Metab Syndr; 2019; 13(2):1623-1627. PubMed ID: 31336531
[TBL] [Abstract][Full Text] [Related]
33. Soluble serum Klotho in diabetic nephropathy: relationship to VEGF-A.
Kacso IM; Bondor CI; Kacso G
Clin Biochem; 2012 Nov; 45(16-17):1415-20. PubMed ID: 22836100
[TBL] [Abstract][Full Text] [Related]
34. Low glomerular filtration rate in normoalbuminuric type 1 diabetic patients: an indicator of more advanced glomerular lesions.
Caramori ML; Fioretto P; Mauer M
Diabetes; 2003 Apr; 52(4):1036-40. PubMed ID: 12663477
[TBL] [Abstract][Full Text] [Related]
35. Progression of diabetic nephropathy.
Hovind P; Rossing P; Tarnow L; Smidt UM; Parving HH
Kidney Int; 2001 Feb; 59(2):702-9. PubMed ID: 11168952
[TBL] [Abstract][Full Text] [Related]
36. Remission of nephrotic-range albuminuria in type 1 diabetic patients.
Hovind P; Rossing P; Tarnow L; Toft H; Parving J; Parving HH
Diabetes Care; 2001 Nov; 24(11):1972-7. PubMed ID: 11679467
[TBL] [Abstract][Full Text] [Related]
37. Microvascular permeability is increased in both types of diabetes and correlates differentially with serum levels of insulin-like growth factor I (IGF-I) and vascular endothelial growth factor (VEGF).
Brausewetter F; Jehle PM; Jung MF; Boehm BO; Brueckel J; Hombach V; Osterhues HH
Horm Metab Res; 2001 Dec; 33(12):713-20. PubMed ID: 11753756
[TBL] [Abstract][Full Text] [Related]
38. Reduction of urinary connective tissue growth factor by Losartan in type 1 patients with diabetic nephropathy.
Andersen S; van Nieuwenhoven FA; Tarnow L; Rossing P; Rossing K; Wieten L; Goldschmeding R; Parving HH
Kidney Int; 2005 Jun; 67(6):2325-9. PubMed ID: 15882275
[TBL] [Abstract][Full Text] [Related]
39. Serum uric acid and progression of diabetic nephropathy in type 1 diabetes.
Pilemann-Lyberg S; Lindhardt M; Persson F; Andersen S; Rossing P
J Diabetes Complications; 2018 May; 32(5):470-473. PubMed ID: 29534864
[TBL] [Abstract][Full Text] [Related]
40. On the pathogenesis of arterial blood pressure elevation early in the course of diabetic nephropathy.
Hommel E; Mathiesen ER; Giese J; Nielsen MD; Schütten HJ; Parving HH
Scand J Clin Lab Invest; 1989 Oct; 49(6):537-44. PubMed ID: 2531916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
